The Use of Drospirenone/Estetrol, Nomegestrol Acetate/Estradiol and Ethinylestradiol/Dienogest in Random Start Rapid Endometrial Preparation

University of Palermo

Status and phase: Completed; Phase 4

Conditions: Endometrial Diseases; Endometrial Polyp

Treatments: Drug: Nomegestrol Acetate / Estradiol; Drug: Drospirenone / Estetrol; Drug: Ethinylestradiol / Dienogest

Study type: Interventional

Funder types: Other

Identifiers

NCT06324851

DROVZOEFFIPREP

Details and patient eligibility

About

The presence of a thin endometrium plays an important role in enabling the best conditions for hysteroscopic surgery. Recently, for this purpose, many studies have evaluated the effect of preoperative administration of a variety of drugs. We explored the efficacy of random started 14-day administration of Drospirenone/Estetrol or Nomegestrol Acetate/Estradiol or Ethinylestradiol/Dienogest, in rapid preparation of endometrium for hysteroscopic polypectomy.

Enrollment: 150 patients

Sex: Female

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Patients with endometrial polyps.

Exclusion criteria

• Patients with other endometrial pathologies.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

150 participants in 3 patient groups

Drospirenone/Estetrol

Experimental group

Description:

Patients with endometrial polyps underwent hysteroscopic polipectomy after starting 14-day treatment with oral Drospirenone/Estetrol at any time of the menstrual cycle

Treatment:

Drug: Drospirenone / Estetrol

Nomegestrol Acetate/Estradiol

Experimental group

Description:

Patients with endometrial polyps underwent hysteroscopic polipectomy after starting 14-day treatment with oral Nomegestrol Acetate/Estradiol at any time of the menstrual cycle

Treatment:

Drug: Nomegestrol Acetate / Estradiol

Ethinylestradiol/Dienogest

Experimental group

Description:

Patients with endometrial polyps underwent hysteroscopic polipectomy after starting 14-day treatment with oral Ethinylestradiol/Dienogest at any time of the menstrual cycle

Treatment:

Drug: Ethinylestradiol / Dienogest